Dezhan HealthCare Co Ltd (000813) - Total Liabilities
Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) has total liabilities worth CN¥271.65 Million CNY (≈ $39.75 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Dezhan HealthCare Co Ltd - Total Liabilities Trend (1995–2025)
This chart illustrates how Dezhan HealthCare Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Dezhan HealthCare Co Ltd (000813) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Dezhan HealthCare Co Ltd Competitors by Total Liabilities
The table below lists competitors of Dezhan HealthCare Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Changbao Steeltube Co Ltd
SHE:002478
|
China | CN¥2.75 Billion |
|
KSB SE & Co. KGaA
XETRA:KSB
|
Germany | €1.55 Billion |
|
Shanghai Hugong Elec(Group)
SHG:603131
|
China | CN¥430.66 Million |
|
Zhejiang Oceanking Development Co Ltd
SHG:603213
|
China | CN¥1.42 Billion |
|
LIVZON PHARMAC. GRP H YC1
F:LP6
|
Germany | €8.61 Billion |
|
Shenzhen Feima International Supply Chain Co Ltd
SHE:002210
|
China | CN¥455.01 Million |
|
Sonaecom SGPS
LS:SNC
|
Portugal | €41.77 Million |
|
SpartanNash Co
NASDAQ:SPTN
|
USA | $1.82 Billion |
Liability Composition Analysis (1995–2025)
This chart breaks down Dezhan HealthCare Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Dezhan HealthCare Co Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 16.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dezhan HealthCare Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dezhan HealthCare Co Ltd (1995–2025)
The table below shows the annual total liabilities of Dezhan HealthCare Co Ltd from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥299.50 Million ≈ $43.83 Million |
+93.37% |
| 2024-12-31 | CN¥154.88 Million ≈ $22.66 Million |
+12.93% |
| 2023-12-31 | CN¥137.15 Million ≈ $20.07 Million |
-64.87% |
| 2022-12-31 | CN¥390.38 Million ≈ $57.13 Million |
+26.73% |
| 2021-12-31 | CN¥308.05 Million ≈ $45.08 Million |
-30.99% |
| 2020-12-31 | CN¥446.37 Million ≈ $65.32 Million |
+41.19% |
| 2019-12-31 | CN¥316.15 Million ≈ $46.26 Million |
-50.61% |
| 2018-12-31 | CN¥640.15 Million ≈ $93.67 Million |
+7.85% |
| 2017-12-31 | CN¥593.57 Million ≈ $86.86 Million |
+238.46% |
| 2016-12-31 | CN¥175.37 Million ≈ $25.66 Million |
-70.74% |
| 2015-12-31 | CN¥599.40 Million ≈ $87.71 Million |
-11.82% |
| 2014-12-31 | CN¥679.75 Million ≈ $99.47 Million |
+38.59% |
| 2013-12-31 | CN¥490.48 Million ≈ $71.77 Million |
+173.19% |
| 2012-12-31 | CN¥179.54 Million ≈ $26.27 Million |
-25.16% |
| 2011-12-31 | CN¥239.89 Million ≈ $35.10 Million |
+12.07% |
| 2010-12-31 | CN¥214.05 Million ≈ $31.32 Million |
+130.97% |
| 2009-12-31 | CN¥92.67 Million ≈ $13.56 Million |
+46.88% |
| 2008-12-31 | CN¥63.09 Million ≈ $9.23 Million |
-47.81% |
| 2007-12-31 | CN¥120.89 Million ≈ $17.69 Million |
-4.91% |
| 2006-12-31 | CN¥127.13 Million ≈ $18.60 Million |
-52.93% |
| 2005-12-31 | CN¥270.09 Million ≈ $39.52 Million |
-37.43% |
| 2004-12-31 | CN¥431.68 Million ≈ $63.17 Million |
-25.95% |
| 2003-12-31 | CN¥582.97 Million ≈ $85.31 Million |
+6.50% |
| 2002-12-31 | CN¥547.41 Million ≈ $80.10 Million |
-3.40% |
| 2001-12-31 | CN¥566.67 Million ≈ $82.92 Million |
-19.87% |
| 2000-12-31 | CN¥707.22 Million ≈ $103.49 Million |
+39.71% |
| 1999-12-31 | CN¥506.21 Million ≈ $74.07 Million |
-1.78% |
| 1998-12-31 | CN¥515.39 Million ≈ $75.42 Million |
-31.46% |
| 1997-12-31 | CN¥751.97 Million ≈ $110.04 Million |
+13.28% |
| 1996-12-31 | CN¥663.82 Million ≈ $97.14 Million |
+0.29% |
| 1995-12-31 | CN¥661.93 Million ≈ $96.86 Million |
-- |
About Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathi… Read more